Cargando…
Comparison of Expectant and Excisional/Ablative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in the Era of HPV Testing
OBJECTIVE: To investigate conservative and excisional/ablative treatment outcomes for cervical intraepithelial neoplasia grade 2 (CIN2) following introduction of virological test of cure. METHODS: This was a retrospective study of prospectively collected data at a teaching hospital colposcopy unit....
Autores principales: | Tjandraprawira, Kevin Dominique, Olaitan, Adeola, Petrie, Aviva, Wilkinson, Nafisa, Rosenthal, Adam N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970964/ https://www.ncbi.nlm.nih.gov/pubmed/35371262 http://dx.doi.org/10.1155/2022/7955290 |
Ejemplares similares
-
HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review
por: Bryan, Stacey, et al.
Publicado: (2019) -
HPV Vaccination in Women with Cervical Intraepithelial Neoplasia Undergoing Excisional Treatment: Insights into Unsolved Questions
por: Henere, Carla, et al.
Publicado: (2022) -
The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions
por: Dovnik, Andraž, et al.
Publicado: (2023) -
microRNAs’ differential regulations mediate the progress of Human Papillomavirus (HPV)-induced Cervical Intraepithelial Neoplasia (CIN)
por: Mo, Wenjuan, et al.
Publicado: (2015) -
Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+)
por: Dorji, Namkha, et al.
Publicado: (2022)